# Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19

> **NCT05200754** · PHASE2 · UNKNOWN · sponsor: **Carsten Müller-Tidow** · enrollment: 174 (estimated)

## Conditions studied

- SARS-CoV-2 Infection

## Interventions

- **OTHER:** Convalescent/Vaccine-boosted Plasma (CP/PVP)

## Key facts

- **NCT ID:** NCT05200754
- **Lead sponsor:** Carsten Müller-Tidow
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09-03
- **Primary completion:** 2022-04
- **Final completion:** 2022-06
- **Target enrollment:** 174 (ESTIMATED)
- **Last updated:** 2022-02-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05200754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05200754, "Trial With or Without Infusion of SARS-CoV-2 Antibody Containing Plasma in High-Risk Patients With COVID-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05200754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*